4 ) measured at the first MRI timepoint did not show any difference between the control and GDM groups but showed a trend towards larger mean placental volumes in the GDM group (control: 137.1 cm 3 vs GDM: 152.1 cm 3 , P = 0.19).
Primary outcome: PFFs incidence The pooled analysis of the three studies showed a trend towards a lower periprosthetic fracture rate in the cemented group compared to the uncemented group (RR = 0.46; 95%CI: 0.14-1.49; P = 0.19) ( Figure 2 ).
As shown in Supplementary Figure S5 , patients receiving tafamidis showed a trend toward improved outcomes for the combined endpoint and the endpoint death/htx ( p = 0.19).
PI-RADS also showed a trend for worse performance, but at a P value of P=0.19 also not significant.
2A-B ), the level of APP showed a trend toward increase ( Figure 2a-b , P = 0.19), and the protein level of Aβ42 was significantly higher in 12-month-old WT mice ( Figure 2a-b , P < 0.05).
Evidence on compliance rate and the risk-reducing effect of aspirin showed a trend to lower incidence of preterm pre-eclampsia with an aspirin adherence ≥90% in comparison to <90% (OR=0.24 vs OR=0.65, p=0.19) 28 .
Linsitinib significantly reduced T-cell infiltration in the orbital fat of the late TSHR-immunized mice ( Figure 5B ), while the early group showed a trend to reduced T-cell infiltration after treatment with linsitinib (p= 0.19).
Furthermore, when stratified by stage, primary OCs showed a trend in higher IL-10 levels with more advanced disease (412.8 pg/mL in advanced stages versus 328.7 pg/mL in early stages for serous OCs; p = 0.19; Figure 1 B).
In ADV-conditioned mice, the frequency and number of CD95 + GL7 + GC B cells increased, and those of class-switched IgG1 + B cells showed a trend to increase (p = 0.19 or 0.18) when compared with those of LD-conditioned mice (Fig. 6F,G ).
Median HR-CTV D 90 > 90 Gy 10 showed a trend toward improved local control (LC) ( p = 0.19).
There were no differences in baseline Glx level between patients who went on to respond to treatment and those who did not, though responders showed a trend to have lower values (14.8 ± 1.2 vs 14.1 ± 0.93 μmol/g, t = 1.38, p = 0.19).
On the other hand, although treatment with tocilizumab showed a trend of improvement in the 28-day mortality as compared to that with the SOC, the improvement was not statistically significant [RR, 0.87 (95% CI, 0.71–1.07), p = 0.19] ( Figure 2B ).
The 2 variants, rs2279343 and rs2279344, showed a trend towards an association ( P = .19 and P = .11, respectively).
Subgroup analysis restricted to studies with anthracyclines chemotherapy showed a trend for improvement in heart failure hospitalization with low heterogeneity (RR 0.44, 95% CI 0.13–1.5, P = 0.19; I 2 = 12%).
Compared to a physical relation, the difference between property and bumping ( M = 4.43, SD = 2.69) showed a trend in the predicted direction that was not statistically significant, t (98) = 1.30, p = .19, d = 0.26.
When soluble protein levels were analyzed as continuous variables using the Cox proportional hazards model, baseline VEGF-C was the only soluble protein significantly associated with TTP by univariate analysis (HR = 0.413; P = 0.0165) and showed a trend towards an association with OS (HR = 0.683; P = 0.190; Table 4 ). sVEGFR-2 ratio to baseline at cycle 1 day 28 was the only soluble protein significantly associated with OS (HR = 0.049; P = 0.0253).
Twenty-eight patients with at least minimal response showed a trend toward lower detection rate of MYD88 L265P mutation (25.0% vs. 66.7%, P = 0.19) and mutant allele burden (median, 0.00% vs. 0.22%, P = 0.07), compared to 3 patients less than minimal response.
MK-801 treatment showed a trend toward increasing pAkt-S473 level ( P = .19).
We found that the RBCK1/HOIL-1L SNV encoding R464H (rs774507518) showed a trend toward an association with primary SS (OR: 2.10, P = 0.19, Table 2 ), though the result was not significant because of limited statistical power.
Neutrophils decreased significantly after IL-2 administration ( p = 0.01), while eosinophils showed a trend towards increased numbers in peripheral blood after IL-2 ( p = 0.19).
Lower Mcl-1 expression showed a trend towards improved OS ( Figure 3 H; p = 0.19) and correlated significantly with disease-free survival (DFS) ( Figure 3 K; p = 0.03).
Although the proportion of COX2‐positive cells among PDGFRα‐positive cells showed a trend toward increase after BDL, this did not reach statistical significance ( p = 0.1905) (Figure 6b ).
Ca displayed a higher concentration in the STZ + HT group compared to the vehicle group (vehicle: 384.50 ± 15.00 mg/kg; STZ + HT: 1572.2 ± 386.29 mg/kg; p = 0.0493; Figure 6 A), whereas STZ group showed a trend without a statistic difference (STZ: 793.36 ± 286.68 mg/kg; p = 0.1909).
The si-CCNE1 and cisplatin (60 μg/kg) with an atelocollagen group showed a trend of decreasing tumor weight compared with the si-control and cisplatin (60 μg/kg) group (274.3 ± 136.4 vs. 420.6 ± 216.4, p = 0.191) ( Figure 7 B). 3.
The 16 children with tumor at optic nerve transection, showed a trend toward higher five-year CSS if they were treated with adjuvant chemoradiation versus no adjuvant treatment (80.0% vs. 45.0%; P = 0.192).